ERIN MCGILL: Open Payments
NPI 1467038265 · ASHEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$939 in 40 payments from 10 companies in 2025. Trend: 2023 $393 · 2024 $693 · 2025 $939
Food & beverage: $939
| Company | Payments | Amount |
|---|---|---|
| ARS Pharmaceuticals Operations, Inc. | 14 | $397 |
| AstraZeneca Pharmaceuticals LP | 6 | $170 |
| GENZYME CORPORATION | 10 | $140 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $60 |
| GlaxoSmithKline, LLC. | 3 | $58 |
| CSL Behring | 1 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| PFIZER INC. | 1 | $25 |
| Blueprint Medicines Corporation | 1 | $18 |
| Galderma Laboratories, L.P. | 1 | $15 |
Products named: NEFFY, DUPIXENT, AIRSUPRA, TAKHZYRO, TRELEGY ELLIPTA, Andembry, PANZYGA, AYVAKIT.
Industry payments across NC — which companies pay providers there.
